Related Experiment Videos

Symposium new drugs for inflammatory, allergic and immunologic disease

J B Summers¹, R D Dyer

¹Abbott Laboratories, Abbott Park, IL 60064, USA.

Agents and Actions. Supplements

|January 14, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Slow-binding inhibition of human prostaglandin endoperoxide synthase-2 with darbufelone, an isoform-selective antiinflammatory di-tert-butyl phenol.

Biochemistry·2001

Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.

Journal of medicinal chemistry·2000

Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain.

The Journal of biological chemistry·1999

Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.

Journal of medicinal chemistry·1999

Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.

Journal of medicinal chemistry·1999

Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors.

Bioorganic & medicinal chemistry letters·1999

See all related articles